Last reviewed · How we verify
Placebo ELLIPTA device — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo ELLIPTA device (Placebo ELLIPTA device) — GlaxoSmithKline. A placebo device with no active pharmaceutical ingredient, used as a control in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo ELLIPTA device TARGET | Placebo ELLIPTA device | GlaxoSmithKline | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo ELLIPTA device CI watch — RSS
- Placebo ELLIPTA device CI watch — Atom
- Placebo ELLIPTA device CI watch — JSON
- Placebo ELLIPTA device alone — RSS
Cite this brief
Drug Landscape (2026). Placebo ELLIPTA device — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-ellipta-device. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing